Petit mal epilepsy and drugs of ingredients of meloxicam (a real world drug study)


Summary:

Petit mal epilepsy is found among people who take drugs with ingredients of meloxicam, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 88,810 people who have side effects when taking drugs with ingredients of meloxicam from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Anjeso, Meloxicam, Mobic, Qmiiz odt, Vivlodex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Jul, 03, 2026

88,810 people reported to have side effects when taking drugs with ingredients of meloxicam.
Among them, 19 people (0.02%) have Petit mal epilepsy


What is Petit mal epilepsy?

Petit mal epilepsy (absence seizure) is found to be associated with 346 drugs and 612 conditions by eHealthMe. Check the latest studies of Petit mal epilepsy.

Number of reports submitted per year:

Could drugs with ingredients of meloxicam cause Petit mal epilepsy?

Time on drugs with ingredients of meloxicam when people have Petit mal epilepsy *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Petit mal epilepsy when taking drugs with ingredients of meloxicam *:

  • female: 76.47 %
  • male: 23.53 %

Age of people who have Petit mal epilepsy when taking drugs with ingredients of meloxicam *:

  • 0-1: 0.0 %
  • 2-9: 7.69 %
  • 10-19: 15.38 %
  • 20-29: 0.0 %
  • 30-39: 15.38 %
  • 40-49: 30.77 %
  • 50-59: 15.38 %
  • 60+: 15.38 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 21.05%
  2. Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 4 people, 21.05%
  3. Insomnia (sleeplessness): 2 people, 10.53%
  4. Allergic Rhinitis: 2 people, 10.53%
  5. Asthma: 2 people, 10.53%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
  7. Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 2 people, 10.53%
  8. Dry Eyes (lack of adequate tears): 2 people, 10.53%
  9. Hypersensitivity: 2 people, 10.53%
  10. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.26%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Premarin: 5 people, 26.32%
  2. Baclofen: 4 people, 21.05%
  3. Tysabri: 4 people, 21.05%
  4. Keppra: 4 people, 21.05%
  5. Oxycontin: 3 people, 15.79%
  6. Zopiclone: 2 people, 10.53%
  7. Hydrocortisone: 2 people, 10.53%
  8. Nasonex: 2 people, 10.53%
  9. Zetia: 2 people, 10.53%
  10. Lamictal Xr: 2 people, 10.53%

Other side effects people have besides Petit mal epilepsy *:

You may use this to check any potential undetected side effects.

  1. Fatigue (feeling of tiredness): 7 people, 36.84%
  2. Memory Loss: 4 people, 21.05%
  3. Confusional State: 4 people, 21.05%
  4. Abdominal Pain Upper: 3 people, 15.79%
  5. Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 3 people, 15.79%
  6. Head Injury: 3 people, 15.79%
  7. Muscle Aches (muscle pain): 3 people, 15.79%
  8. Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 3 people, 15.79%
  9. Fall: 3 people, 15.79%
  10. Drowsiness: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of meloxicam, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: